Portal de investigación
ESTUDIO OBSERVACIONAL PROSPECTIVO Y MULTICÉNTRICO PARA LA IDENTIFICACIÓN DE BIOMARCADORES PRONÓSTICOS Y PREDICTORES DE RESPUESTA A SUNITINIB EN PACIENTES CON TUMORES BIEN O MODERADAMENTE DIFERENCIADOS DE ISLOTES PANCREÁTICOS CON ENFERMEDAD METASTÁSICA EN PROGRESIÓN.
Datos básicos
- Código:
- SAL-SUN-2011-01
- Protocolo:
- SAL-SUN-2011-01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2013
- Año de finalización:
Objetivos del proyecto
Observaciones: Estado Comité: ACTIVO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
Martínez-Trufero J; (...); Gutiérrez A
Article. 10.3390/cancers13040792. 2021
A multicenter phase 2 study of nivolumab combined with ipilimumab in patients with pediatric solid tumors in adulthood (GETHI021).
Mielgo, Xabier; (...); Garcia-Donas, Jesus
Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.TPS3123. 2018
A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)
Capdevila, J; (...); Manzano, JL
Meeting Abstract. 10.1016/j.annonc.2020.08.1373. 2020
Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution
Bruixola, G; (...); Aparicio, J
Article. 10.5301/tj.5000344. 2015
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib
Diaz-Beveridge, R; (...); Aparicio, J
Article. 10.1007/s12094-017-1720-4. 2018
Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib.
Jiménez-Fonseca P; (...); Grande E
Article. 10.18632/oncotarget.26380. 2018
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study
de Juan I; (...); Bolufer P
Article. 10.1007/s10689-015-9814-z. 2015
Buenas practicas para el uso seguro de las bolsas tricamerales de nutricion parenteral.
Sirvent M; (...); Grupo de Nutrición Clínica de la SEFH
Abstract of Published Item. 10.7399/fh.2014.38.5.8085. 2014
Cancer worry at higher-risk sample of hereditary cancer in Spain.
Costa-Requena G, Richart-Aznar P, Segura-Huerta Á
Article. 10.1097/CEJ.0000000000000862. 2024
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
Frezza, Anna Maria; (...); Gronchi, Alessandro
Article. 10.1002/cam4.5015. 2022
Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.
Ortiz A; (...); Rodriguez M
Article. 10.1159/000528784. 2023
Clinical guideline SEOM: hepatocellular carcinoma
Sastre J; (...); Feliu J
Article. 10.1007/s12094-015-1451-3. 2015
Clinical Utility (CU) Evaluation of the Health-Related Quality-of-Life (HRQoL) QLQ-GINET21 Questionnaire (QNR) in the Treatment of Patients (pts) with Gastrointestinal (GI) Neuroendocrine Tumors (NETs). QUALINETS Study
Gallego, J; (...); Benavent, M
Meeting Abstract. 2018
Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (> 5 years) to frontline imatinib (IM): A case-control study from GEIS
Serrano, C; (...); Broto, JM
Meeting Abstract. 2017
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib
Serrano, C; (...); Carles, J
Article. 10.1634/theoncologist.2018-0032. 2019
CNL and aCML should be considered as single entity based on molecular profiles and outcomes.
Carreño-Tarragona G; (...); Cross, Nicholas C. P.
Article. 10.1182/bloodadvances.2022008204. 2022
Comparison of psychological distress for breast, ovarian and colorectal cancer predisposition in a Spanish sample at high risk of hereditary cancer.
Costa-Requena, Gema; (...); Segura-Huerta, Angel
Article. 10.1097/CEJ.0000000000000734. 2022
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Hidalgo, M; (...); Carrato, A
Article. 10.1007/s12094-016-1594-x. 2017
Controversies in the multimodality management of locally advanced rectal cancer
Díaz Beveridge R; (...); Aparicio, J
Review. 10.1007/s12032-017-0964-8. 2017
Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; (...); Soto JL
Article. 10.1002/cac2.12134. 2021
Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.
Ochenduszko, Sebastian; (...); Maiques, Inmaculada Maestu
Article. 10.1111/pcmr.13093. 2023
Diagnostic demographics of radioiodine-refractory differentiated thyroid cancer (RR-DTC) and usage patterns of local and systemic therapies (ERUDIT study)
Lopez, C; (...); Rodriguez-Villanueva, J
Meeting Abstract. 10.1016/j.annonc.2020.08.1412. 2020
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.
Capdevila, J.; (...); Manzano, J. L.
Article. 10.1038/s41467-023-38611-5. 2023
Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE)
Soria, A.; (...); Cerezuela-Fuentes, P.
Meeting Abstract. 10.1016/j.annonc.2023.09.2248. 2023
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).
Marquez-Rodas, Ivan; (...); Berrocal, Alfonso
Article. 10.1093/neuonc/noae116. 2024
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis
Capdevila J; (...); García Alfonso P
Article. 10.1186/s12885-015-1512-6. 2015
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
Jimenez-Fonseca, Paula; (...); Garcia-Carbonero, Rocio
Article. 10.1159/000514808. 2021
Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer
Bruixola G; (...); Santaballa A
Article. 10.1097/IGC.0000000000000330. 2015
First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma
Gonzalez, J. A.; (...); Lopez Pousa, A.
Meeting Abstract. 10.1016/j.annonc.2023.09.1161. 2023
First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas
Gonzalez-Lopez, Jose Antonio; (...); Pousa, Antonio Lopez
Meeting Abstract. https://doi.org/10.1016/j.annonc.2023.09.1161. 2024
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
Martin-Broto, J; (...); Lopez-Pousa, A
Article. 10.1093/annonc/mdx536. 2017
Guidelines for diagnosis, staging and treatment of metastatic colorectal cancer by Grupo Espanol Multidisciplinar en Cancer Digestivo (GEMCAD)
Aguilar, G; (...); Zorrilla, M
Review. 10.2217/CRC.15.9. 2015
Heart failure as first sign of development of cardiac metastases in a patient with diagnosis of papillary thyroid carcinoma on treatment with tyrosine-kinase inhibitors: differential diagnoses and clinical management.
Bruixola G; (...); Díaz-Beveridge R
Article. 10.1159/000366192. 2014
Histological Differentiation Provides Useful, Additive and Independent Prognostic Information to Proliferation Index in G2 and G3 Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Canovas, MS; (...); Garcia-Carbonero, R
Meeting Abstract. 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Gronchi A; (...); Casali PG
Article. 10.1016/S1470-2045(17)30334-0. 2017
Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.2147/OTT.S214319. 2019
Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine
Murria R; (...); Bolufer P
Article. 2015
ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma
Martin Broto, Javier; (...); Hindi, Nadia
Meeting Abstract. 2023
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)
Ramirez-Calvo, M; (...); Lopez-Guerrero, JA
Article. 10.1186/s13053-019-0104-x. 2019
Initial Clinical and Treatment Patterns of Advanced Differentiated Thyroid Cancer. ERUDIT Study.
Vallejo Casas, Juan Antonio; (...); Orcajo-Rincon, Lorenzo
Article. 10.1530/ETJ-21-0111. 2022
Interim analysis of a phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumors in adulthood (GETHI021).
Mielgo, X; (...); Garcia-Donas, J
Meeting Abstract. 10.1200/JCO.2019.37.15_suppl.2613. 2019
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Gonzalez-Cao M; (...); Berrocal A
Article. 10.1038/s41467-021-26572-6. 2021
Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
Marquez-Rodas, I; (...); Berrocal, A
Meeting Abstract. 10.1016/j.annonc.2021.08.1423. 2021
Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage.
Chicas-Sett R; (...); Tormo A
Article. 10.7759/cureus.572. 2016
Lanreotide 120 mg every 28 days (LAN) in patients with locally advanced or metastatic pancreatic neuroendocrine tumors (panNET) in routine clinical practice in Iberia
Alonso-Gordoa, T.; (...); de La Cruz, G.
Meeting Abstract. 2022
Management and supportive treatment of frail patients with metastatic pancreatic cancer
Macarulla, T; (...); Hidalgo, M
Review. 10.1016/j.jgo.2018.06.005. 2019
Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice.
Diaz Beveridge R; (...); Montalar J
Article. 10.6092/1590-8577/1570. 2014
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Sevilla, I; (...); Grande, E
Article. 10.1186/s12885-016-2901-1. 2016
Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer
Murria R; (...); Bolufer P
Article. 2015
Microbiome preterm birth DREAM challenge: Crowdsourcing machine learning approaches to advance preterm birth research.
Golob JL; (...); Sirota M
Article. 10.1016/j.xcrm.2023.101350. 2024
MOLTHY project (TTCC-2020-02): A Spanish observational study for MOLecular characterization of THYroid carcinoma
Baste Rotllan, N.; (...); Mesia, R.
Meeting Abstract. 10.1016/j.annonc.2023.09.999. 2023
Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer
Alvarez Gallego, R.; (...); Cubillo, A.
Meeting Abstract. 10.1016/j.annonc.2023.04.238. 2023
Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience
Diaz-Beveridge, R; (...); JORGE APARICIO URTASUN
Article. 10.1097/MPH.0000000000000339. 2015
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
Gronchi, Alessandro; (...); Casali, Paolo Giovanni
Article. 10.1200/JCO.23.00908. 2024
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Pasquali, Sandro; (...); Gronchi, Alessandro
Article. 10.1002/cncr.33895. 2022
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Gronchi, A; (...); Casali, PG
Article. 10.1200/JCO.19.03289. 2020
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
Gronchi, Alessandro; (...); Casali, Paolo Giovanni
Meeting Abstract. 2022
Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
Alvarez, R; (...); Hidalgo, M
Review. 10.1007/s12094-017-1680-8. 2017
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Nunez-Valdovinos, B; (...); Garcia-Carbonero, R
Article. 10.1634/theoncologist.2017-0364. 2018
New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis
Valle, L; (...); Blanco, I
Article. 10.1093/hmg/ddu058. 2014
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)
Maurel, J; (...); Fernandez-Cruz, L
Article. 10.1007/s00280-018-3682-9. 2018
Pancreatic cancer, Radiomics and Artificial Intelligence: A Review.
Marti-Bonmati L; (...); Alberich-Bayarri A
Article. 10.1259/bjr.20220072. 2022
Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.
del Olmo-Garcia, Maria I.; (...); Merino-Torres, Juan F.
Article. 10.3390/cancers14030584. 2022
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol
Salazar, Juliana; (...); Sebio, Ana
Article. 10.3390/pharmaceutics16121585. 2024
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Macarulla, T; (...); Hidalgo, M
Article. 10.1200/JCO.18.00089. 2019
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS).
Martin-Broto J; (...); Hindi N
Article. 10.1200/JCO.24.00358. 2024
Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).
Broto, Javier Martin; (...); Hindi, Nadia
Meeting Abstract. 2022
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ortuzar, Ariana; (...); Osorio, Santiago
Article. 10.1007/s00277-022-05044-x. 2022
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
Benavent M; (...); Gallego J
Article. 10.1186/s12955-021-01688-x. 2021
Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature
Bruixola G; (...); Aparicio J
Review. 10.1016/j.lungcan.2014.07.012. 2014
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.
Carmona-Bayonas A; (...); García-Carbonero R
Article. 10.1200/JCO.19.00980. 2019
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience
Berlanga, Pablo; (...); Castel, Victoria
Article. 10.1097/MPH.0000000000000270. 2015
Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families
Fonfria, M; (...); Martinez-Duenas, E
Article. 10.3390/jpm11060548. 2021
Prevalence of germline MUTYH mutations among Lynch-like syndrome patients
Castillejo A; (...); Soto JL
Article. 10.1016/j.ejca.2014.05.022. 2014
Primary Mesenteric Undifferentiated Pleomorphic Sarcoma Masquerading as a Colon Carcinoma: A Case Report and Review of the Literature.
Diaz-Beveridge R; (...); Aparicio J
Article. 10.1155/2015/532656. 2015
Prognostic role of HMG proteins in a series of 301 advanced soft tissue sarcoma patients: A Spanish Group for Sarcoma Research Study (GEIS).
Hindi, N; (...); Broto, JM
Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.11573. 2018
Psychiatric symptoms in a Spanish sample with hereditary cancer risk.
Costa-Requena G; (...); Segura-Huerta Á
Article. 10.1007/s12687-022-00580-5. 2022
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Dalgleish, AG; (...); Mudan, SS
Article. 10.1038/bjc.2016.271. 2016
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain
Alvarez-Gallego, Rafael; (...); Cubillo, Antonio
Article. 10.1177/17588359241309828. 2025
Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation.
Ochenduszko, Sebastian; (...); Maestu, Inmaculada
Meeting Abstract. 2022
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Curras-Freixes, M; (...); Robledo, M
Article. 10.1136/jmedgenet-2015-103218. 2015
Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities
Vanzulli, Andrea; (...); Gronchi, Alessandro
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.11553. 2024
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.
Vanzulli, A; (...); Gronchi, A
Article. 10.1016/j.esmoop.2025.104299. 2025
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer
Estal, RM; (...); Gilabert, PB
Article. 10.1007/s10689-015-9864-2. 2016
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).
Martin-Broto J; (...); Lopez-Pousa A
Article. 10.1634/theoncologist.2018-0121. 2019
Results of phase II randomized study of intermittent versus continuous schedule of vemurafenib plus cobimetinib in BRAF-mutated advanced melanoma.
Gonzalez-Cao, Maria; (...); Berrocal, Alfonso
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.9528. 2021
RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II
Alvarez, A.; (...); Marquez Rodas, I.
Meeting Abstract. 2023
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
Imedio ER; (...); Salcedo JM
Article. 10.1007/s12032-014-0948-x. 2014
Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).
García-Fernández FJ; (...); Moradi Kolbolandi M
Article. 10.1093/eurheartj/ehz067. 2019
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Gounder, Mrinal M.; (...); Attia, Steven
Article. 10.1200/JCO.21.01829. 2022
SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
Poveda, A; (...); Martin-Broto, J
Article. 10.1007/s12094-016-1579-9. 2016
SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
Martin-Richard M; (...); Rivera F
Article. 10.1007/s12094-016-1577-y. 2016
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).
Castillón JC; (...); Plazas JG
Article. 10.1007/s12094-023-03205-6. 2023
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy.
Pasquali, Sandro; (...); Gronchi, Alessandro
Article. 10.1016/j.ebiom.2024.105220. 2024
The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study
Pipa-Muniz, M; (...); Varela, M
Article. 10.1016/j.gastrohep.2017.05.009. 2017
Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain
Turnes, J; (...); Viudez, A
Article. 10.1016/j.gastrohep.2014.11.001. 2015
Translational research in neuroendocrine tumors: pitfalls and opportunities
Capdevila, J; (...); Castano, JP
Review. 10.1038/onc.2016.316. 2017
Treatment patterns of adjuvant interferon-alpha 2b for high-risk melanoma: a retrospective study of the Grupo Espanol Multidisciplinar de Melanoma - Prima study
Espinosa, E; (...); Martin-Algarra, S
Article. 10.1097/CMR.0000000000000254. 2016
Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients
Carmena, MD; (...); Martin, AM
Meeting Abstract. 10.1093/annonc/mdz155.189. 2019
Use Of Iodine-131 (RAI) For The Initial Diagnosis And Treatment Of Differentiated Thyroid Cancer (DTC) In Spain And Portugal (ERUDIT Study)
Casas, JV; (...); Orcajo, L
Meeting Abstract. 2020
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data
Romero, R; (...); Nicolaides, KH
Review. 10.1002/uog.17397. 2017
Validation of a risk score for post-engraftment invasive fungal disease in 414 adult allogeneic hematopoietic stem cell transplant recipients
Montesinos, P.; (...); Sanz, M. A.
Meeting Abstract. 2016
Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre
Salvador, C.; (...); Aparicio, J.
Meeting Abstract. 10.1016/S0959-8049(16)31204-7. 2015